An interventional study of Innovative Swallowing Pressure Measurement Ball Combined With CTAR Training and Conventional Swallowing Rehabilitation in Stroke, Dysphagia and Post-Stroke Dysphagia, sponsored by Chimei Medical Center. Recruiting at 1 site in Taiwan. Open to participants aged 65 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-06-03.
Sponsored by Chimei Medical Center · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 394 studies in Stroke with a site in Taiwan — 73 open to participants now, 82 under way, 4 of them phase 3. Stroke · Taiwan.
Among the 394 studies in Stroke with a site in Taiwan, this one is the 68th largest by planned enrollment of the 337 interventional ones that give a count, is one of 9 that started in 2026, is one of 261 with no phase, reaches primary completion later than 38 of the 81 other live ones, and was the 389th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →73 of the 394 studies in Stroke with a site in Taiwan are open now. Recruiting first, the newest first:
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 20–80
National Cheng-Kung University Hospital · Sites in Taiwan
Ages 20–80 · Healthy volunteers
I-Shou University · Sites in Taiwan
Ages 20–80
Eli Lilly and Company · Sites in Taiwan, Argentina, Australia and 35 more countries
Ages 50+
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 20+ · Healthy volunteers
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 65 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
394 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 17 · Phase 2 26 · Phase 3 37 · Phase 4 5
First in 1998; this study’s year is marked. 9 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 132 is above the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 54 across the 337 interventional studies, 100 across the 56 observational. Of the 207 that completed or were terminated, 15 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
36 of 394 have an industry lead sponsor. The 10 most frequent:
Chimei Medical Center is the lead sponsor of 28 studies on the registry; 6 are open to participants now.
Chimei Medical Center has 2 studies filed under Stroke — fewer than ten, so there is no comparison to draw.
20 of the studies in Stroke with a site in Taiwan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06204744Chang Gung Memorial HospitalHome-based Arm and Hand Exercise Program for Stroke: A Multisite Trial | 2026-12 |
| NCT06854497Chiayi Christian HospitalThe Impact of Non-motor Symptom on the Outcome of Stroke Subjects | 2026-12-31 |
| NCT04874454National Taiwan University HospitalEvaluating Potential Risk of Choking by Laryngeal Ultrasound in Patients With Acute Stroke | 2026-12-31 |
| NCT07620210Chimei Medical CenterEffects of CTAR and a Swallowing Pressure Ball in Older Stroke Adults | 2026-12-31 |
| NCT06883357National Taiwan University HospitalThe Effects of Home-based Graded Repetitive Arm Supplementary Program Group on Stroke. | 2026-12-31 |
Add all 20 to your calendar (.ics) → With an account.
Among the 394 studies in Stroke with a site in Taiwan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to investigate the effectiveness of resistance swallowing rehabilitation using Chin Tuck Against Resistance (CTAR) exercises combined with an innovative swallowing pressure ball in improving swallowing function and swallowing-related quality of life among home-based older stroke patients with dysphagia.
Participants will receive a 12-week swallowing rehabilitation program conducted in the home-care setting. Outcome measures include swallowing function assessments, swallowing-related quality of life, and rehabilitation adherence. The study is designed as a randomized controlled trial to explore the feasibility and clinical benefits of resistance-based swallowing rehabilitation in community and home-care environments.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Device: Innovative Swallowing Pressure Measurement Ball Combined With CTAR Training
Behavioral: Conventional Swallowing Rehabilitation
Participants receive Chin Tuck Against Resistance (CTAR) swallowing training combined with an innovative swallowing pressure measurement ball intervention twice daily for 12 weeks.
Participants receive conventional swallowing rehabilitation including tongue resistance exercise and oral motor control training.
Swallowing Quality of Life Questionnaire (SWAL-QOL) Total Score
Swallowing-related quality of life assessed using the Swallowing Quality of Life Questionnaire (SWAL-QOL). The total score ranges from 44 to 220 points, with higher scores indicating better swallowing-related quality of life.
Time frame: Baseline to Week 12
GOKURI Swallowing Function and Cough Events
Swallowing function assessed using the GOKURI wearable swallowing monitoring system. Outcomes include the frequency of cough events and swallowing-related acoustic signals. Lower cough event frequency indicates better swallowing safety and function.
Time frame: Baseline to Week 12
Plan to share: Undecided
No publications or documents are linked to this record.
Started Mar 2026 (actual). Primary completion is estimated for Dec 2026, 9 months after the start.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 9 months is below that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chimei Medical Center